GLP-1 Tracker App for Android: Ours Is iPhone Only

GLP-1 Tracker is built for iPhone and is available only on the App Store. There is no Android app, no listing on Google Play, and no browser version that mirrors it. Nothing further down this page ends in a Play Store button, because there is not one to give you.

That is worth saying in the first paragraph rather than three scrolls down. A lot of pages that rank for this question are written to keep an Android reader moving toward a download that turns out to be for a different phone, or toward a general "best apps" roundup that quietly omits which platform each entry actually runs on. If you have ever tapped through a comparison table only to land on an App Store page while holding an Android phone, you already know how that feels.

So the app is not an option for you today, and we are not going to dress that up. What follows is the part that is genuinely useful: what a good GLP-1 tracker looks like on Android, what to check before you install one, why small apps so often appear on iOS first, and a way to keep a solid record starting this afternoon without installing anything at all.

Start with cadence, because it is the thing most general health apps get wrong. Some GLP-1 medications are a once-weekly injection and others are taken daily, and an app built around a daily habit loop will nag you six days out of seven if your routine is weekly. Before you commit, check that the reminder can be set to the rhythm your prescriber actually gave you.

Then the record itself. You want a dose log with the date and, for injections, the site you used, so rotation is a glance rather than a memory test. You want weight stored as a trend rather than a single number, because day-to-day water weight will hide real progress if you only ever see today. You want a place to note side effects with a date attached, since "it was rough for a few days after the last step up" is a far more useful sentence at an appointment when you can say which days.

Food logging deserves its own thought. On a GLP-1 the constraint is usually not willpower but appetite, so an app that only counts calories down is pointed the wrong way. Protein is the number most people are told to watch, because weight lost without enough of it is more likely to include muscle. Look for a food log that surfaces protein rather than burying it three taps under a calorie ring.

One check that is specific to Android and easy to miss: reminders. Android device makers layer their own battery management on top of the operating system, and background notifications are exactly what that management likes to kill. Set a reminder, then see whether it still fires reliably a week later. If it does not, look in your phone's battery settings for an option to exempt the app, and if it still cannot manage a weekly notification, that is a real reason to try something else.

The most common failure is the paywall placed under the basics. Recording a dose is the single thing a dose tracker exists to do, and an app that will not let you do it more than a handful of times before asking for a subscription has made the free tier a demo rather than a tool. Judge an app by what it lets you do on day thirty, not day one.

The second is drift into advice. A tracker that starts hinting you are due for an increase, or reading a symptom back to you as though it knows what caused it, has quietly turned itself into something it is not qualified to be. This is not a small distinction. Titration schedules are individual and set by a prescriber, and an app has no idea about your history, your other medications, or how the last few weeks actually went.

The third is inherited DNA from ordinary diet apps. Many GLP-1 trackers began life as calorie counters, and it shows in the tone: aggressive deficits, streak shaming, a home screen built to make you eat less. Appetite suppression is already doing that part. What people on these medications more often need is help eating enough of the right things, and an app fighting that instinct becomes something you delete in week three.

The fourth is harder to see from the listing: who pays for the app. A free health app has to be funded somehow, and if the answer is advertising, referrals, or routing you toward a particular telehealth prescriber, that is a conflict of interest sitting between you and your own data. It does not make an app dishonest, but it is worth knowing before you type your weight into it.

The last is the exit. Plenty of apps are perfectly good until you want to leave, at which point a year of dose history turns out to be locked inside them.

Read the Data safety section on the Google Play listing before you install. It is a required declaration and it tells you what the developer says the app collects, what it shares with third parties, and whether collection is optional. Compare that against what the app plausibly needs. A dose log asking to share health information with advertising partners is answering the funding question for you.

Look at the permissions the app requests, both on the listing and at first launch. Recording an injection needs no access to your contacts, your precise location, your call log, or your messages. A camera permission makes sense for progress photos or meal photos, and notifications make sense for reminders. Anything beyond the obvious deserves a reason, and Android lets you grant permissions individually and revoke them later in Settings.

Check how it handles Health Connect, which is the shared health data layer on modern Android phones. An app that can read and write there fits into the rest of your phone instead of becoming an island, so a weight you record once can appear elsewhere without retyping. The important part is that it is your call: Health Connect shows you exactly which data types an app can read and write, and you can withdraw that access at any time without uninstalling anything.

Find the export before you need it. A CSV, a PDF, or even a plain email of your own records is enough. Try it once in the first week, while you have nothing to lose.

And look at who publishes the app. A named developer, a support address that reaches a person, and a privacy policy written in language you can actually read are all quiet signals. One firm rule regardless of platform: do not sideload a health app from an APK site outside the Play Store. You lose the review, the update path, and any idea of what you have actually installed.

This is an explanation, not an excuse, and it is worth being plain about which one it is. GLP-1 Tracker is made by one independent developer, not a company with platform teams, and one person shipping two platforms usually means shipping both of them badly. Choosing a single operating system and doing it properly is the trade, and the reader on the wrong side of that trade is you.

The practical reasons are ordinary. iOS means a single programming language and one toolchain across a narrow, predictable range of devices, so a layout that works on a test phone works nearly everywhere. HealthKit gives a single well-documented place for health data. Android's strengths are the other side of that coin: an enormous range of devices, screen sizes, manufacturer skins and battery-management behaviours, which is genuinely good for the people buying phones and genuinely more work for one developer testing them. The reminder problem described earlier is a small example of a large category.

What we will not do is turn that into a promise. There is no Android version in development that we are teasing, no timeline, no waitlist, and no coming-soon banner, because there is no commitment behind any of those things. All that is true today is that the app runs on iPhone and does not run on Android. If that changes, it will change on the App Store and Google Play, not in a paragraph like this one.

The honest recommendation for an Android reader is not an app at all, and it is better than it sounds. A spreadsheet in Google Sheets covers every important thing a GLP-1 tracker does: a row per week, columns for the date of your dose, the injection site, your weight, your protein for the day, and a note about how you felt. It takes about ten minutes to set up, it costs nothing, and the file is permanently yours in a format nothing can lock. There is a step-by-step build guide on this site, covering the columns worth having and the ones that seem useful but never get filled in.

The cost of a spreadsheet is arithmetic and prompting: nothing reminds you, and every trend line is work you do yourself. A calendar event repeating on injection day covers the first problem in about thirty seconds. For the second, the browser-based tools on this site run fine in Chrome on Android because they run entirely inside the page on your own device. The BMI calculator will do the number you would otherwise be recalculating by hand each month, without an account and without sending anything anywhere.

That combination, a repeating calendar reminder, a sheet you actually fill in, and a browser tool for the arithmetic, is not a consolation prize. Plenty of people would be better served by it than by an app they abandon in a month. The point of tracking is to arrive at your next appointment able to describe what really happened rather than what you remember, and a spreadsheet does that perfectly well.

And if you found this page on an iPhone, or you are reading it on a laptop and carry an iPhone: GLP-1 Tracker is for you. It is a free download that logs doses, injection sites, weight and BMI, progress photos and side effects, estimates calories, protein and fiber from a photo of your plate with protein shown first, sends dose reminders, and draws an educational medication-level estimate from the doses you have recorded. It tracks Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus and Saxenda among others, works in eleven languages, and keeps everything you enter stored on your device, never uploaded to our servers and never sold. It is independent and not affiliated with any drug manufacturer. It is a tracking and education tool, not a medical device, and every decision about your medication stays with your prescriber.